| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 102.897 | 190.215 | 231.605 | 334.725 | 242.673 | 312.771 | 378.460 | 422.613 | 447.513 | 464.017 |
| Total Income - EUR | 105.453 | 194.059 | 239.279 | 334.796 | 252.156 | 331.791 | 378.460 | 422.613 | 447.648 | 468.444 |
| Total Expenses - EUR | 103.840 | 193.593 | 235.840 | 327.199 | 248.323 | 319.463 | 374.320 | 409.422 | 424.233 | 456.269 |
| Gross Profit/Loss - EUR | 1.613 | 466 | 3.438 | 7.597 | 3.833 | 12.328 | 4.140 | 13.191 | 23.415 | 12.175 |
| Net Profit/Loss - EUR | 1.050 | 142 | 1.046 | 4.249 | 1.353 | 9.272 | 1.163 | 9.771 | 19.608 | 227 |
| Employees | 3 | 4 | 5 | 5 | 7 | 7 | 8 | 8 | 8 | 8 |
Check the financial reports for the company - Leg Bio Prod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 517 | 187 | 0 | 0 | 0 | 0 | 0 | 0 | 50.669 |
| Current Assets | 20.636 | 29.741 | 59.239 | 26.444 | 39.242 | 32.915 | 30.320 | 35.519 | 55.010 | 35.633 |
| Inventories | 20.611 | 29.604 | 55.528 | 25.522 | 35.707 | 29.381 | 27.802 | 33.342 | 47.588 | 26.835 |
| Receivables | 0 | 0 | 44 | 877 | 2.957 | 2.112 | 2.241 | 1.597 | 1.825 | 3.451 |
| Cash | 24 | 137 | 3.667 | 45 | 578 | 1.422 | 277 | 580 | 5.597 | 5.347 |
| Shareholders Funds | -15.105 | -14.809 | -13.513 | -9.016 | -7.682 | 1.736 | 2.860 | 12.640 | 32.209 | 32.256 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.741 | 45.067 | 72.939 | 35.460 | 46.924 | 31.179 | 27.459 | 22.879 | 22.801 | 54.045 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Leg Bio Prod Srl